As reported, EGFR is a key element in colorectal cancers (23), and many documents point to EGFR as a biomarker of cancers such as head and neck squamous cell carcinomas and primary non-small cell lung cancer (24, 25). This evidence concerns the gene EGFR and non-small cell lung carcinoma.